Faculty

Institution

Unit

Venue

Richard J. Pietras

University of California, Los Angeles

Affiliations

the College

California Nanosystems Institute (cnsi)

NoneRichard J. Pietras is currently serving as a California Nanosystems Institute (Cnsi) faculty at University of California, Los Angeles.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Richard J. Pietras

University of California, Los Angeles

You can click a keyword to filter the displayed items

pharmacology oncology endocrinology cancer research medicinal research cancer biology breast cancer radiation oncology cancer treatment cancer care tumor biology cell biology medicine thoracic oncology lung cancer cancer immunotherapy anti-cancer agents membrane biology tumor targeting endocrine oncology breast oncology cellular therapy cancer management cancer genomics endocrine research oncogenes cancer cells pharmacotherapy respiratory medicine molecular cancer enzyme inhibition protein science gynecologic oncology mammalian biology vascular biology steroid metabolism cancer prevention triple-negative breast cancer cellular physiology reproductive biology oncogenic agent receptor (biochemistry) cancer risk signaling pathways cancer genetics drug targeting hormonal receptor cancer growth estrogen receptors epithelial cells treatment effects host specificity therapeutic efficacy female reproductive system reproductive physiology cell regulation human breast estrogen receptor antidiuretic hormone positron emission tomography comparative endocrinology cellular biology cell physiology genitourinary cancers molecular substrates experimental biology human breast cancers isolated endometrial cells ovarian cancer cells breast cancer response aromatase inhibitors steroid hormones steroid hormone receptors toad urinary bladder potential target phase ii study

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 599: Combination of Cdk4/6 Inhibitors With Biguanides for Treatment of Triple Negative Breast Cancer. Cancer Research (2024)

Mario Morales MartinezEduardo Mauricio GonzalezGang DengGaoyuan MaHyunsoo KimLinsey StilesNalo HamiltonMichael E. JungRichard J. PietrasDiana C. Marquez-Garban

cancer immunotherapyanti-cancer agentsoncologyradiation oncologycancer researchcancer biologycancer managementcancer carepharmacologycancer treatmentdrug targetingenzyme inhibitionclinical researchbreast cancermedicinal research

Abstract C024: Evaluation of Pi3K/Akt/Mtor Pathway Signaling as a Prognostic Indicator in Hispanic Mexican Women With Breast Cancer. Cancer Epidemiology Biomarkers & Prevention (2024)

Mario Morales MartinezGiovanny Soca-ChafreAltagracias Maldonado-ValenzuelaClara M Rivera-PazosGabriela Antonio-AndresMayra Montecillo-AguadoGeorgina Rocha-LopezBerenice Alcala-Mota-VelazcoAnel Gomez-GarciaMadhuri WadehraRichard J PietrasSergio Gutierrez-CastroSara Huerta-YepezDiana Marquez-Garban

signaling pathwayscancer researchprognostic evaluationprognostic indicatorprognostic biomarkerscancer preventionbreast cancerepidemiologybiomarkers

CORRECTION: Hamilton Et Al. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2017, 18, 2305. International Journal of Molecular Sciences (2024)

Nalo HamiltonDavid AustinDiana Márquez-GarbánRudy SanchezBrittney ChauKay FoosYanyuan WuJaydutt VadgamaRichard Pietras

receptorstumor biologycancer genomicsreceptor (biochemistry)oncologyendocrinologytriple-negative breast cancermolecular sciencecancer biologybreast oncologyimmunologypharmacologytumor targetingmolecular biologybreast cancermedicinal research

Emp2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer. Cancers (2024)

Ann M. ChanBrian AguirreLucia LiuVei MahJustin M. BalkoJessica TsuiNavin P. WadehraNeda A. MoatamedMahdi KhoshchehrehChristen M. DillardMeagan KiyoharaYahya ElshimaliHelena R. ChangDiana Marquez-GarbanNalo HamiltonRichard J. PietrasLynn K. GordonMadhuri Wadehra

cancer immunotherapycancer biologybreast oncologypharmacologyfunctional biomarkercancer preventiontumor biologycellular therapyoncologycancer researchcancer carecancer genomicsanti-cancer agentsradiation oncologybreast cancermedicinal researchcancer imagingenzyme inhibitionhealth sciences

Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models. Nutrients (2024)

Diana C. Márquez-GarbánCristian D. YanesGabriela LlarenaDavid ElashoffNalo HamiltonMary HardyMadhuri WadehraSusan A. McCloskeyRichard J. Pietras

cancer researchcancer biologypharmacologyhealth sciencespreclinical modelsbreast cancer

Retraction Note: A83-01 Inhibits Tgf-β-Induced Upregulation of Wnt3 and Epithelial to Mesenchymal Transition in Her2-Overexpressing Breast Cancer Cells. Breast Cancer Research and Treatment (2024)

Yanyuan WuTrinh TranSami DwabeMarianna SarkissyanJuri KimMiguel NavaSheilah ClaytonRichard PietrasRobin Farias-EisnerJaydutt V. Vadgama

tumor biologymedicineoncologycancer researchcell regulationcancer biologycell biologycell signalingcancer cellscancer managementretraction notecancer carepharmacologycancer treatmentcancer geneticsbreast cancermedicinal research

Abstract 510: Targeting Metabolic Vulnerabilities to Reduce Triple Negative Breast Cancer Health Disparities. Cancer Research (2023)

Diana C. Márquez-GarbanGang DengLorena P. BurtonGaoyuan MaVishaka MuhunthanBegonya Comin-AnduixGabriela LlarenaNeda MoatamedJennifer MurphyNalo HamiltonDaivd ShackelfordMichael E. JungRichard J. Pietras

metabolismoncologycancer researchpharmacologytumor targetinghealth sciencescancer preventionbreast cancermetabolic vulnerabilities

Data From Aromatase Expression Predicts Survival in Women With Early-Stage Non–Small Cell Lung Cancer. (2023)

Vei MahDavid B. SeligsonAi LiDiana C. MárquezIgnacio I. WistubaYahya ElshimaliMichael C. FishbeinDavid ChiaRichard J. PietrasLee Goodglick

lung cancertumor biologycancer genomicsoncologycancer researchcancer growthcancer biologyprognosisbiostatisticsthoracic oncologypharmacologylife predictionsurvival analysishealth sciences

Estradiol Induces Neutrophil Expansion to Promote Tsc-Null Tumor Progression. Endocrinology (2023)

Diana C Marquez-GarbanMario Morales MartinezRichard J Pietras

hematologytsc-null tumor progressiononcologyendocrinologyimmunologyendocrine oncologyhealth sciencesendocrine research

Evolving Perspectives on the Treatment of Hr+/Her2+ Metastatic Breast Cancer. Therapeutic Advances in Medical Oncology (2023)

Mark PegramRichard PietrasChau T. DangRashmi MurthyThomas BachelotWolfgang JanniPriyanka SharmaErika HamiltonCristina Saura

metastasiscancer immunotherapysurgical oncologymedicineanti-cancer agentsoncologyradiation oncologycancer researchcancer biologycancer managementcancer carepharmacologycancer treatmenttumor targetingbreast cancermedicinal researchpharmacotherapy

1
2
3
4
5
12
10 / page

Richard J. Pietras

University of California, Los Angeles

Affiliations

the College

California Nanosystems Institute (cnsi)

NoneRichard J. Pietras is currently serving as a California Nanosystems Institute (Cnsi) faculty at University of California, Los Angeles.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Richard J. Pietras

University of California, Los Angeles

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 599: Combination of Cdk4/6 Inhibitors With Biguanides for Treatment of Triple Negative Breast Cancer. Cancer Research (2024)

Mario Morales MartinezEduardo Mauricio GonzalezGang DengGaoyuan MaHyunsoo KimLinsey StilesNalo HamiltonMichael E. JungRichard J. PietrasDiana C. Marquez-Garban

Abstract C024: Evaluation of Pi3K/Akt/Mtor Pathway Signaling as a Prognostic Indicator in Hispanic Mexican Women With Breast Cancer. Cancer Epidemiology Biomarkers & Prevention (2024)

signaling pathwayscancer researchprognostic evaluationprognostic indicatorprognostic biomarkerscancer preventionbreast cancerepidemiologybiomarkers

Nalo HamiltonDavid AustinDiana Márquez-GarbánRudy SanchezBrittney ChauKay FoosYanyuan WuJaydutt VadgamaRichard Pietras

Emp2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer. Cancers (2024)

Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models. Nutrients (2024)

Diana C. Márquez-GarbánCristian D. YanesGabriela LlarenaDavid ElashoffNalo HamiltonMary HardyMadhuri WadehraSusan A. McCloskeyRichard J. Pietras

cancer researchcancer biologypharmacologyhealth sciencespreclinical modelsbreast cancer

Retraction Note: A83-01 Inhibits Tgf-β-Induced Upregulation of Wnt3 and Epithelial to Mesenchymal Transition in Her2-Overexpressing Breast Cancer Cells. Breast Cancer Research and Treatment (2024)

Yanyuan WuTrinh TranSami DwabeMarianna SarkissyanJuri KimMiguel NavaSheilah ClaytonRichard PietrasRobin Farias-EisnerJaydutt V. Vadgama

Abstract 510: Targeting Metabolic Vulnerabilities to Reduce Triple Negative Breast Cancer Health Disparities. Cancer Research (2023)

metabolismoncologycancer researchpharmacologytumor targetinghealth sciencescancer preventionbreast cancermetabolic vulnerabilities

Data From Aromatase Expression Predicts Survival in Women With Early-Stage Non–Small Cell Lung Cancer. (2023)

Vei MahDavid B. SeligsonAi LiDiana C. MárquezIgnacio I. WistubaYahya ElshimaliMichael C. FishbeinDavid ChiaRichard J. PietrasLee Goodglick

lung cancertumor biologycancer genomicsoncologycancer researchcancer growthcancer biologyprognosisbiostatisticsthoracic oncologypharmacologylife predictionsurvival analysishealth sciences

Estradiol Induces Neutrophil Expansion to Promote Tsc-Null Tumor Progression. Endocrinology (2023)

Diana C Marquez-GarbanMario Morales MartinezRichard J Pietras

hematologytsc-null tumor progressiononcologyendocrinologyimmunologyendocrine oncologyhealth sciencesendocrine research

Evolving Perspectives on the Treatment of Hr+/Her2+ Metastatic Breast Cancer. Therapeutic Advances in Medical Oncology (2023)

Mark PegramRichard PietrasChau T. DangRashmi MurthyThomas BachelotWolfgang JanniPriyanka SharmaErika HamiltonCristina Saura

1
2
3
4
5
12
10 / page

Similar Faculty Members

David J. Waxman

Institution

Boston University

molecular cancer

cancer genomics

Patricia K. Donahoe

Institution

Harvard University

developmental system

developmental endocrinology

Shantu Amin

Institution

Pennsylvania State University

cancer letter

polycyclic aromatic hydrocarbon

John Koomen

Institution

University of South Florida

proteomics

chemical cleavage mechanisms

David Gewirtz

Institution

Virginia Commonwealth University

pharmacology

breast cancer

Donald McDonnell

Institution

Duke University

pharmacology

endocrinology

Owen Witte

Institution

University of California, Los Angeles

immunology

genetics

Ann Richmond, Ph.D

Institution

Vanderbilt University

immunology

molecular cancer

Matteo Pellegrini

Institution

University of California, Los Angeles

gene expression

epigenetics

Rafael Fridman

Institution

Wayne State University

proteases

cancer biology

Similar Faculty Members

David J. Waxman

Institution

Boston University

molecular cancer

cancer genomics

Patricia K. Donahoe

Institution

Harvard University

developmental system

developmental endocrinology

Shantu Amin

Institution

Pennsylvania State University

cancer letter

polycyclic aromatic hydrocarbon

John Koomen

Institution

University of South Florida

proteomics

chemical cleavage mechanisms

David Gewirtz

Institution

Virginia Commonwealth University

pharmacology

breast cancer

Donald McDonnell

Institution

Duke University

pharmacology

endocrinology

Owen Witte

Institution

University of California, Los Angeles

immunology

genetics

Ann Richmond, Ph.D

Institution

Vanderbilt University

immunology

molecular cancer

Matteo Pellegrini

Institution

University of California, Los Angeles

gene expression

epigenetics

Rafael Fridman

Institution

Wayne State University

proteases

cancer biology